Magellan Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.9M Buy
83,187
+7,605
+10% +$4.13M 0.53% 47
2025
Q4
$43.8M Sell
75,582
-34,165
-31% -$19.3M 0.53% 39
2025
Q3
$53.2M Buy
109,747
+97,298
+782% +$45.3M 0.63% 38
2025
Q2
$5.05M Buy
12,449
+6,678
+116% +$2.79M 0.06% 64
2025
Q1
$2.87M Hold
5,771
0.03% 72
2024
Q4
$3M Buy
+5,771
New +$3.17M 0.03% 65

Other funds holding TMO

Magellan Asset Management's TMO Position: Q1 2026 in Review

Magellan Asset Management increased its Thermo Fisher Scientific (TMO) stake by 10% in Q1 2026, buying an estimated $4.13M and bringing the position to 83,187 shares worth $40.9M. The position accounts for 0.53% of the portfolio, ranked #47.

Magellan Asset Management first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $53.2M in Q3 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Magellan Asset Management held 83,187 shares of Thermo Fisher Scientific worth $40.9M as of Q1 2026.
  • Magellan Asset Management bought 7,605 Thermo Fisher Scientific shares in Q1 2026, an estimated $4.13M.
  • Thermo Fisher Scientific made up 0.53% of Magellan Asset Management's portfolio in Q1 2026, its #47 holding.
  • Magellan Asset Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Magellan Asset Management's Thermo Fisher Scientific position peaked at $53.2M in Q3 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Magellan Asset Management's 13F filing for Q1 2026, filed 12 May 2026.